Clinical Research Manager
Psych/Public Mental Health & Population Sciences
United States of America
Dr. Filippou-Frye received her medical degree from University of Crete Medical School in Greece. Beginning in 2005 with neuroscience as her primary focus, she has assembled a strong portfolio of medical conference presentations and publications. A UCLA clinical research fellowship followed her medical degree, where she was responsible for coordinating and managing multiple international and in-house clinical trials. Augmenting her clinical trials experience, she attended Keck Graduate Institute (KGI) and graduated with Master in Bioscience (MBS). This program has provided an invaluable growth opportunity reflecting the need to merge detailed scientific data into the language of business performance and process design.
Dr. Filippou-Frye’s clinical research capabilities, FDA regulations knowledge, industry knowledge and the skills required to effectively translate comprehensive medical data to health care and business professionals led her to the current position at Stanford University.
Tight glycemic control increases metabolic distress in traumatic brain injury: A randomized controlled within-subjects trial CRITICAL CARE MEDICINE Vespa, P., McArthur, D. L., Stein, N., Huang, S., Shao, W., Filippou, M., Etchepare, M., Glenn, T., Hovda, D. A. 2012; 40 (6): 1923-1929
Early metabolic crisis-related brain atrophy and cognition in traumatic brain injury BRAIN IMAGING AND BEHAVIOR Wright, M. J., McArthur, D. L., Alger, J. R., Van Horn, J., Irimia, A., Filippou, M., Glenn, T. C., Hovda, D. A., Vespa, P. 2013; 7 (3): 307-315
Effect of a Novel NMDA Receptor Modulator, Rapastinel (Formerly GLYX-13), in OCD: Proof of Concept. The American journal of psychiatry Rodriguez, C. I., Zwerling, J., Kalanthroff, E., Shen, H., Filippou, M., Jo, B., Simpson, H. B., Burch, R. M., Moskal, J. R. 2016; 173 (12): 1239–41